Recent developments in artificial intelligence (AI) have led to significant breakthroughs in the field of medicine, particularly in the design and validation of novel antibiotics. A study published in Nature Machine Intelligence highlights the use of generative AI for creating easily synthesizable and structurally novel antibiotics. Additionally, the first true AI-designed drug aimed at curing a fatal lung condition has been announced, showcasing AI's capability to identify targets and design effective drugs. Researchers have also developed an AI model that inhibits the growth of Acinetobacter baumannii, a common drug-resistant bacteria, marking a significant step forward in combating antibiotic resistance. These advancements suggest that AI could play a crucial role in addressing some of the most challenging diseases and potentially extend healthcare to all.